AXM Pharma (AXMP) Stock Price, News & Analysis

Company Overview

AXM Pharma, Inc. (OTCMKTS:AXMP) is a clinical-stage specialty pharmaceutical company headquartered in New Jersey. The company is dedicated to identifying, acquiring and advancing novel dermatology products through late-stage clinical development. AXM Pharma’s core focus is on prescription treatments for skin and soft tissue infections, with a mission to address unmet medical needs in wound care and antimicrobial therapy.

AXM Pharma’s lead asset is TCD-11091, a topical formulation designed to treat diabetic foot ulcers and other complicated skin infections. The company is conducting clinical trials to evaluate the safety and efficacy of this therapy, with the goal of demonstrating faster healing times and a favorable tolerability profile compared to existing treatment options. Development efforts are supported by preclinical and early-stage data suggesting broad-spectrum antimicrobial activity.

In pursuit of global reach, AXM Pharma is exploring strategic collaborations and licensing agreements to facilitate future commercialization across the United States and select international markets. The company leverages partnerships with contract research organizations and specialty distributors to optimize its clinical trial execution and eventual product launch capabilities.

AXM Pharma is guided by a management team with expertise in dermatology drug development, regulatory affairs and commercial strategy. By focusing on a targeted dermatology portfolio and streamlined clinical programs, the company aims to efficiently bring new treatments to patients living with challenging skin conditions.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 1,000 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 7/20/2026
• Fiscal Year End: 6/30/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:AXMP
• CIK: N/A
• Web: www.axmpharma.net
• Phone: (702) 932-7980
• Fax: N/A
• Employees: 150
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 2.15